Multi-Step Regulation of the TLR4 Pathway by the miR-125a~99b~let-7e Cluster by Curtale, Graziella et al.
ORIGINAL RESEARCH
published: 07 September 2018
doi: 10.3389/fimmu.2018.02037
Frontiers in Immunology | www.frontiersin.org 1 September 2018 | Volume 9 | Article 2037
Edited by:
Alessandra Mortellaro,
Istituto San Raffaele Telethon per la
Terapia Genica (SR-Tiget), Italy
Reviewed by:
Carlo Pucillo,
Università degli Studi di Udine, Italy
Marit Inngjerdingen,
Oslo University Hospital, Norway
Ana Rebane,
University of Tartu, Estonia
*Correspondence:
Graziella Curtale
gcurtale@gmail.com
Massimo Locati
massimo.locati@unimi.it
†Present Address:
Massimiliano Mirolo,
Roche Glycart AG, Schlieren,
Switzerland
Marzia Rossato,
Department of Biotechnology,
University of Verona, Verona, Italy
Specialty section:
This article was submitted to
Molecular Innate Immunity,
a section of the journal
Frontiers in Immunology
Received: 30 March 2018
Accepted: 17 August 2018
Published: 07 September 2018
Citation:
Curtale G, Renzi TA, Mirolo M,
Drufuca L, Albanese M, De Luca M,
Rossato M, Bazzoni F and Locati M
(2018) Multi-Step Regulation of the
TLR4 Pathway by the
miR-125a∼99b∼let-7e Cluster.
Front. Immunol. 9:2037.
doi: 10.3389/fimmu.2018.02037
Multi-Step Regulation of the TLR4
Pathway by the
miR-125a∼99b∼let-7e Cluster
Graziella Curtale 1,2*, Tiziana A. Renzi 1,2, Massimiliano Mirolo 1,2†, Lorenzo Drufuca 1,2,
Manuel Albanese 1, Mariacristina De Luca 1, Marzia Rossato 3†, Flavia Bazzoni 3 and
Massimo Locati 1,2*
1Department of Medical Biotechnologies and Translational Medicine, University of Milan, Milan, Italy, 2Humanitas Clinical and
Research Center, Rozzano, Italy, 3Department of Medicine, Division of General Pathology, University of Verona, Verona, Italy
An appropriate immune response requires a tight balance between pro- and
anti-inflammatory mechanisms. IL-10 is induced at late time-points during acute
inflammatory conditions triggered by TLR-dependent recognition of infectious agents and
is involved in setting this balance, operating as a negative regulator of the TLR-dependent
signaling pathway. We identified miR-125a∼99b∼let-7e as an evolutionary conserved
microRNA cluster late-induced in human monocytes exposed to the TLR4 agonist LPS
as an effect of this IL-10-dependent regulatory loop. We demonstrated that microRNAs
generated by this cluster perform a pervasive regulation of the TLR signaling pathway
by direct targeting receptors (TLR4, CD14), signaling molecules (IRAK1), and effector
cytokines (TNFα, IL-6, CCL3, CCL7, CXCL8). Modulation of miR-125a∼99b∼let-7e
cluster influenced the production of proinflammatory cytokines in response to LPS
and the IL-10-mediated tolerance to LPS, thus identifying this gene as a previously
unrecognized major regulatory element of the inflammatory response and endotoxin
tolerance.
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INTRODUCTION
The innate immune system detects infections via the recognition of various pathogen-associated
molecules by means of specific families of pattern recognition receptors, including Toll-like
receptors (TLR). TLR triggers signaling cascades leading to the production of pro-inflammatory
cytokines, which promote inflammation at the site of infection and coordinate the immune
response. To efficiently induce protection from pathogens, the inflammatory response must be
balanced by inhibitory pathways promoting its own resolution and allowing tissue healing and
regeneration. For its well documented anti-inflammatory role, mainly based on the ability to
inhibit production of pro-inflammatory cytokines and simultaneously increase anti-inflammatory
molecules, Interleukin 10 (IL-10) is a fundamental element of such balance. This anti-inflammatory
mediator, which is produced with delayed kinetics after LPS recognition, operates as a key mediator
of resolution of the acute inflammatory response and is involved in the LPS desensitization process,
also known as endotoxin tolerance (1–3). Conversely, in case of pathogen persistence lymphocyte-
derived signals contribute to establish a chronic immune response. Among these, a major role is
played by the Th1-derived IFNγ, which counteracts IL-10 biological activities and reverses (4) the
endotoxin tolerance state.
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MicroRNA (miR) are endogenous small non-coding RNA
molecules which function as post-transcriptional regulators of
gene expression by recognizing short complementary miR-
responsive elements (MRE) within the 3′-untranslated region
(3′UTR) of target mRNA (5). MiR are involved in several
biological processes, including the fine tuning of innate immune
responses (6). TLR triggering in particular set in motion a
regulatory network supported by a defined set of miR which
finely tunes the TLR signaling pathway (7–15). MiR are also
involved in the resolution phase of inflammation, as reported for
miR-466l which promotes inflammation when early expressed in
polymorphonuclear neutrophils and contributes to its resolution
when expressed at later time points in macrophages engaged
by apoptotic neutrophils (16). In this setting, miR activity is
tightly connected with other anti-inflammatory mediators, as
exemplified by the inhibitory effect of IL-10 on the expression
of the proinflammatory miR-155 (17) and, on the other hand, by
the recent identification of some miR, including miR-146b and
miR-187, which are directly induced by IL-10 and contributes
to its anti-inflammatory activities, thus acting as intracellular
mediators of this and other pro-resolving mediators (14, 18,
19). Similarly, we recently reported that the glucocorticoid-
responsive miR-511-5p controls the TLR4 signaling pathway
(20). This study further contributes to the molecular definition
of this complex network describing the anti-inflammatory miR-
125a∼99b∼let-7e cluster, which is late-induced by TLR agonists
via the IL-10-dependent regulatory loop and operates a pervasive
negative regulation on the TLR signaling pathway controlling a
particularly wide set of target genes involved in this pathway.
We show the biological relevance of this miR-mediated regulatoy
network by providing evidence of its involvement in the IL-10-
mediated tolerance to LPS, thus candidating this miR cluster as a
key feedback modulator of the inflammatory response.
MATERIALS AND METHODS
Reagents
LPS from E. coli (serotype 055:B5), palmitoyl-3-cysteine-serine-
lysine-4 (pam3CSK4), imiquimod, CpG DNA oligonucleotide,
and poly (I:C) were from Enzo Life Sciences. IL-10 and TGFβ
were from R&D System. IFNγ and IL-1β were from Peprotech.
AG-490 was from Calbiochem. Antibodies for ChIP of Pol II
(rabbit polyclonal N-20; sc-899) and STAT3 (rabbit polyclonal
C-20; sc-482) were from SantaCruz Biotechnology. The ChIP-
grade rabbit polyclonal anti-Sp1 antibody (clone 07-645) and
the monoclonal mouse anti-NF-kB p65 (RelA; clone CS2043599)
were from Millipore. Mouse anti-rabbit IgG-HRP (sc-2357)
and goat anti-mouse IgG-HRP (sc-2005) were from SantaCruz
Biotechnology. Mouse monoclonals anti-IFNγR1 (clone 92101)
and anti-IL-10Rα (clone AF-274-NA) were from R&D systems.
The LEAF purified mouse IgG1k isotype control clone MG-1-45
was from Biolegend. The rabbit polyclonal anti-SMAD2/3 (clone
3102) was from Cell Science Technology.
Primary Cells and Cell Lines
Human monocytes were obtained from healthy donor buffy
coats, upon approval by Humanitas Research Hospital
Ethical Committee. Cells were isolated by two-steps gradient
centrifugation using Ficoll (Biochrom) and Percoll (Amersham)
followed by incubation of purified cells in RPMI 1640 (Lonza)
without serum for 10min at 37◦C with 5% CO2. Adherent
monocytes were washed twice with PBS and then cultured in
RPMI medium supplemented with 10% fetal bovine serum (FBS;
Lonza), 100 U/mL penicillin/streptomycin (Lonza), and 2mM
L-glutamine (Lonza). Monocyte purity was >90% as assessed by
CD14/CD16 flow cytometry analysis. The human THP-1 cells
(ATCC) were maintained by twice weekly passages in RPMI
1640 medium containing 10% heat-inactivated FBS, 100 U/mL
penicillin-streptomycin, 25mM L-glutamine at 37◦C with 5%
CO2. HEK-293T cells (ATCC) were grown in DMEM medium
(Cambrex) supplemented with 10% heat-inactivated FBS, 100
U/mL penicillin-streptomycin, and 25mM L-glutamine at 37◦C
with 5% CO2.
Quantification of miRNAs and Coding
Transcripts
Total RNA was isolated from cell cultures with TRIzol (Ambion)
according to the manufacturer’s instructions, and was quantified
at nanodrop by its absorption at 260 nm. The A260/A230
ratio was checked to estimate nucleic acid purity. Agarose gel
electrophoresis was performed using 1µ extracted RNA to assess
its integrity and evaluate the presence of contaminant genomic
DNA. For quantification of miR expression, 300 ng of total
RNA were reverse transcribed using TaqMan R© MiRNA Reverse
Transcription kit (Applied Biosystems), as previously described
(14). Quantitative real-time PCR (Q-PCR) was conducted
using a 7900HT Real-time PCR System. Three replicates per
each experimental point were performed, and differences were
assessed with a 2-tailed Student t-test. Results were normalized
on U6 levels according to the 11 cycle threshold method and
where indicated they are expressed as the relative change (-fold)
of the stimulated group over the control group, which was used
as a calibrator. The list of oligonucleotides used is reported in
Table S1.
Constructs Generation
To evaluate miR activity, the 3′UTRs of target genes were
amplified from genomic DNA and cloned in the biosensor
psiCHECKTM-2 vector (Promega). Pre-miR-125a∼99b∼let7e,
pre-miR-125a, pre-miR-99b, and pre-let-7e were amplified
from genomic DNA and subsequently cloned in the pcDNA3
expression vector, using the pCR2.1 vector (Invitrogen) as
subcloning vector. To knockdown miR expression, sponge
constructs (miR-125a-5p sponge and let7e-5p sponge) containing
multiple sequential repeats of miR imperfect complementary
seed site regions were cloned into a psiCHECKTM-2 vector
(Promega). The fragment containing the SV40 promoter together
with the renilla luciferase gene fused to the miR sponge fragment
was then subcloned into the pRRLSIN.CPPT.PGK.GFP.WPRE
vector (plasmid #12252; Addgene) in an antisense orientation
with respect to the GFP cassette. The expression of the luciferase
reporter gene was checked to assess the efficacy of miR inhibition.
A lentiviral construct encoding for a hairpin yielding a 22-mer
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RNA designed to lack homology to any human gene was used as
control.
Luciferase Reporter Assay
HEK-293T cells were plated in 24-well plates in DMEM
supplemented with 10% FBS and 1% of L-glutamine at 16
× 104/well and after 24 h were transfected with 100 ng
psiCHECKTM-2-3
′
-UTR reporter construct and 10µMmirVana
miR mimics (Life Technologies) using Lipofectamine 2000
(Invitrogen), according to the manufacturer’s protocol. After 48 h
from transfection, cells were lysed and firefly and renilla luciferase
activities were determined using the Dual-Glo Luciferase Assay
System (Promega), according to manufacturer’s instructions. The
enzymatic activities of the two luciferases were quantified using
a MultiDetection Microplate Reader Synergy 2 luminometer
(BioTek). The values of renilla luciferase activity were normalized
by firefly luciferase activity, which served as internal control, and
expressed as fold changes relative to the value of the negative
control.
Chromatin Immunoprecipitation (ChIP)
Assay
ChIP experiments were performed as previously described
(14). Briefly, sheared chromatin from 5 × 106 monocytes was
immunoprecipitated ON at 4◦C with the relative antibody and
1% of starting chromatin was used not immunoprecipitated and
used as input. Q-PCR was performed in triplicates using primers
reported in Table S1. Signals obtained from the ChIP samples
were normalized on signals obtained from corresponding input
samples, according to the formula: 100 × 2(input Ct−sample Ct).
Results were expressed as fold enrichment relative to untreated
cells.
Flow Cytometry and Surface Staining
Cells were washed twice with PBS containing 1% BSA and
unspecific binding was blocked using Fc-block (BD Biosciences).
Washed cells were resuspended in a 1:200 dilution of APC-
conjugated anti-human TLR4 antibody (clone HTA125 from
eBioscience), anti-human CD14 antibody (clone 61D361 from
eBioscience) or the mouse APC-conjugated IgG2a isotype
control (eBioscience) and incubated for 1 h at 4◦C. Stained
cells were washed twice with PBS containing 1% BSA and then
analyzed by flow cytometry (FACS Canto, BD Biosciences).
LPS Desensitization
Monocytes were cultured in 24-well plates in 500 µl RPMI
supplemented with 10% FBS and 1% L-glutamine, pretreated
or not ON with 10 ng/ml IFNγ, primed or not with 0.1 ng/ml
LPS for 18 h, and then challenged with 10 ng/ml LPS. THP-1
cells, transduced with miRT-125a-5p sponge or control vectors,
were cultured in 24-well plates in 500 µl RPMI supplemented
with 10% FBS and 1% L-glutamine, pretreated or not ON with
10 ng/ml IFNγ, primed or not with 50 ng/ml TGFβ or 10 ng/ml
IL-10 for 2 h, and then challenged with 100 ng/ml LPS. In both
experimental settings, cell lysates and supernatants were collected
at 48 h.
Immunoprecipitation of Ago2-Bound RNAs
(RIP)
RIP experiments were performed as previously described (14,
20). Briefly, immunoprecipitations were carried out ON at 4◦C
using protein G sepharose magnetic beads (GE Healthcare)
conjugated with anti-Ago2 (EIF2C2 monoclonal antibody clone
2E12-1C9; Abnova) or an isotype IgG1k control antibody
(Abnova). Sequences of 3’UTR mRNA-specific primers used in
Q-PCR are listed in Table S1. After immunoprecipitation an
aliquot of supernatants corresponding to 0.5× 106 cell equivalent
(indicated as “leftover”) was removed and used as control for
the specificity of the assay. The miR/mRNA enrichment to the
RNA-induced silencing complex (RISC) complex was calculated
according to the formula: 2−(CtAgo−CtIgG). Results were expressed
as fold enrichment relative to Ago2-IP CT samples.
Western Blot Analysis
Protein lysates and Western blots were performed as previously
described (19). Transfected THP-1 cells (5 × 106) were
harvested, incubated at 4◦C for 5min with 1mM diisopropyl
fluorophosphate, and lysed in 40mM Tris, 1% SDS, 7.5%
glycerol. 100 µg of the total cell lysate was boiled for 10min
at 95◦C, resolved on 10% SDS-PAGE, and transferred to
nitrocellulose (Hybond; GE Healthcare). Blots were incubated
with anti-IRAK1 (clone D51G7 from Cell Science Technology)
and anti-β actin (clone C4; sc-47778 from SantaCruz
Biotechnology) antibodies and then probed with appropriate
HRP-conjugated secondary antibodies (donkey anti-rabbit IgG
LNA934V/AG and sheep anti-mouse IgG LNXA931/AE from
Amersham, respectively).
ELISA Assay
Cytokine levels (TNFα, CCL3, CXCL8, IL-6, IL-12p40, CCL7,
CCL2, CXCL10) present in the cell culture supernatant of
transduced THP-1 cells stimulated for the indicated times with
LPS or IFNγ were measured using the human Duoset ELISA
kit (R&D Systems), according to the manufacturer’s instructions.
Samples were diluted so that the optical density fell within the
optimal portion of a log standard curve.
Bioinformatics Analysis
Predicted target genes of each miR were defined using the
microrna.org database (21). The enrichment analysis of GO
terms was performed through the analysis tool available from the
Panther Classification System (22). Statistical overrepresentation
test (Bonferroni test) was performed using default setting. The
analysis of biological functions and associated networks was
determined using the Ingenuity Pathway Analysis software (IPA;
Ingenuity Systems) by applying the “expression in immune cells”
filter and the built-in Fisher exact test. The relationship of
the miR-125a∼99b∼let-7e cluster with the 124 genes included
in the Inflammatory response network shown in Figure 6 was
graphically visualized using IPA. The probability score of each
the miR-125a∼99b∼let-7e cluster to be involved in this network
was calculated according to the formula: miRx = −1/log2[(Txǫ
N)/124], where T = number of predicted target genes of miRx
and N= number of genes included in the Inflammatory response
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network. The statistical value of the involvement in the TLR
signaling pathway, as identified by IPA, was defined by fitting
the target distribution to Gaussian functions with mean 25.74
and SD 11.40. Evolutionary conserved regions and transcription
factor binding sites were identified using the Mulan software
(http://mulan.dcode.org) (23) and visualized in Figure 2 using
the Jalview 2.8 software (www.jalview.com) (24).
Statistical Analysis
Statistical evaluation was determined using the Student t-test
or the one-way ANOVA and p-values are reported in figures
(∗ <0.05; ∗∗ <0.01; ∗∗∗ <0.001).
RESULTS
The miR-125a∼99b∼let-7e Cluster Is
Induced by IL-10 and TGFβ
To identify miR potentially involved in the response to stimuli of
bacterial origin, we have previously analyzed the miR expression
profile of monocytes stimulated with 100 ng/ml of the TLR4
agonist LPS (8). Under these conditions, we reported that the
panel of LPS-induced miRs included miR-125a-5p, let-7e-5p,
and miR-99b-5p (Figures 1A–C). These three miR represent
the mature products of the miR-125a∼99b∼let-7e cluster,
encoded by a conserved region hosted in the first intron of
the linc 00085 gene in human chromosome 19 (Figure 2A).
This miR cluster was induced to similar extent to LPS also
by the TLR2 agonist pam3CSK4 and the proinflammatory
cytokine IL-1β, while agonists at intracellular TLRs, such as
the TLR3 agonist poly (I:C), the TLR7 agonist imiquimod,
and a CpG oligodeoxynucleotide (CpG DNA oligo) agonist at
TLR9, were inactive (Figures 1A–C). Interestingly, when other
anti-inflammatory mediators were tested, TGFβ and IL-10 were
also able to increase the expression of miR-125a∼99b∼let-
7e cluster, while glucocorticoids (Dex) were inactive
(Figures 1A–C).
The transcriptional regulation of the miR-125a∼99b∼let-
7e cluster was further investigated by evaluating by ChIP the
engagement of cis regulatory elements on predicted binding sites
included in its putative proximal promoter region, located by
bioinformatics analysis within 2 kb upstream its transcription
start site (TSS) (Figure 2A). The increased expression of the
miR cluster observed upon LPS challenge was accompanied
by a comparable recruitment of Pol II at the core promoter
region of the miR-125a∼99b∼let-7e cluster and also at the
promoter of miR-155, a well-known LPS-responsive miR used as
a positive control (25) (Figure 2B). Conversely, after exposure
to IL-10 or TGFβ, monocytes showed Pol II recruitment
on the promoter region of the miR-125a∼99b∼let-7e cluster
but not on the miR-155 promoter, here used as a negative
control being negatively regulated by IL-10 (17) (Figure 2B).
Consistent with the positive effect of IL-10 and TGFβ on
the expression of the miR-125a∼99b∼let-7e cluster, binding
of the IL-10-dependent transcription factor STAT3 and TGFβ-
dependent transcription factor SMAD3 to highly conserved
binding sites was also evident after short-term exposure to IL-
10 and TGFβ, respectively (Figures 2C,D). Interestingly, LPS but
not IL-10 also induced engagement of the transcription factor
NF-kB, suggesting its involvement on miR induction after LPS
(Figure 2E).
The LPS-dependent induction of the miR-125a∼99b∼let-
7e cluster occurred with a delayed kinetic as compared to
other miRs directly induced by LPS, such as miR-155 (8, 25),
suggesting the involvement of secondmediators (Figures 3A–C).
Indeed IL-10, which is late induced in monocytes after LPS
exposure (2, 26, 27), was able to upregulate miR-125a-5p,
miR-99b-5p, and let-7e-5p expression (Figures 1A–C, 3A–C)
and potentiated their induction by LPS (Figures 3A–C). Of
note, LPS, IL-10, and TGFβ, but not Dex, also induced an
enrichment of mature miRs into the RNA-induced silencing
complex (RISC) complex (Figures 3D–F), indicating that these
miRs are functionally active in monocytes. Furthermore, when
the activity of the endogenous IL-10 late induced after TLR4
engagement was blocked, either by an anti-IL-10R blocking
monoclonal antibody or the JAK/STAT signaling pathway
inhibitor AG-490 compound (28), a significant reduction of
miR-125a-5p, miR-99b-5p, and let-7e-5p induction by LPS was
observed (Figures 3G–I). IFNγ is a key mediator of chronic
FIGURE 1 | Regulation of the miR-125a∼99b∼let-7e cluster expression. Expression of miR-125a-5p, let-7e-5p, and miR-99b-5p in monocytes cultured for 24 h with
100 ng/mL LPS, 2µg/mL pam3CSK4, 3µg/mL imiquimod, 50µg/mL poly(I:C), 1µM CpG DNA, 25 ng/mL IL-1β, 50 ng/mL IL-10, 50 ng/mL TGFβ, 20 ng/mL Dex
(A–C). MiR-125a-5p (A), let-7e-5p (B) and miR-99b-5p (C) were measured by Q-PCR in triplicate samples. Results expressed as fold change over control (mean ±
SEM; n = 4). (*<0.05; **<0.01; ***<0.001).
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FIGURE 2 | Transcriptional regulation of miR-125a∼99b∼let-7e cluster. (A) Sequence homology between human (chr.19: 52191745-52196592) and murine (chr.
17:17827604-17832451) miR-125a∼99b∼let-7e loci was analyzed by pairwise sequence local alignment using the TBA alignment program and visualized as a
conservation plot generated by the Mulan software. Red blocks identify evolutionary conserved regions (ECR) with >50% identity between the two species over 100
bp segments. The transcription start site (TSS), TATA boxes (black squares), and the putative binding sites for transcription factors are indicated. (B–E) ChIP assays
were carried out on human monocytes stimulated or not for 4 h with 25 ng/ml IL-10, 100 ng/ml LPS or 50 ng/ml TGFβ using anti-Pol II (B) Abs or for 12 h with
anti-STAT3 (C), anti-SMAD3 (D), or anti-NF-kB (E) antibodies. Q-PCR was carried out using specific primers for the miR-125a∼99b∼let-7e promoter (black columns
in panels B–E) or the miR-155 promoter (white columns in panel B). Results are expressed as fold change over control (mean ± SEM; n = 3). (* <0.05; ** <0.01;
*** <0.001).
inflammation and is known to show positive synergistic effects
with LPS and negative synergism with IL-10 (4). Consistently,
treatment with IFNγ reduced miR-125a∼99b∼let-7e expression
at early time-points and abolished its induction by the IL-
10-dependent loop observed at late time-points after LPS
stimulation (Figures 4A–C). Of note, upon stimulation IFNγ
efficiently recruited the SP1 trancription factor at the most distal
binding site on the cluster promoter (Figure 4D). Taken together,
these data identify the miR-125a∼99b∼let-7e cluster as an IL-
10 and TGFβ responsive gene, negatively modulated by IFNγ,
and suggest its involvement in the complex feedback regulatory
mechanism controlling the inflammatory response after TLR
engagement.
MiR-125a-5p and let-7e-5p Directly Target
the TLR Signaling Pathway at Multiple
Levels
To uncover the biological functions of miRs encoded by
this cluster and to gain insights into their functional role
in the context of LPS-mediated inflammation, we examined
the gene onthology categories associated to the predicted
target genes of the three miRs. A significant enrichment
of genes involved in the Immune system process (GO term
0002376) was observed for miR-125-5p and let-7e-5p (miR-
125a-5p: 171 genes, p = 3.52 × 10−3; let-7e-5p: 93 genes,
p = 2.11 × 10−2) but not miR-99b-5p (29 genes, p =
0.787). Of note, the list of predicted targets associated to
this specific genonthology cathegory showed in particular a
highly significant enrichment of the functional annotation
Macrophage activation (GO term 0042116) for miR-125-5p
and let-7e-5p, but not for miR-99b-5p (Figure 5A). Consistent
with this, the intersection between the predicted targets
of each miR of the cluster and biological pathways as
defined by IPA indicated a significant enrichment of genes
associated to biological functions related to inflammation
(Inflammatory response, Immune cell trafficking, Cell-mediated
immune response) for miR-125a-5p and, to a less extent,
let-7e-5p, but not miR-99b-5p, which was not related to
any of these functions (Figure 5B). Finally, the IPA analysis
of the predicted target genes of miR-125a-5p and let-7e-5p
generated an “inflammatory network” centered on the TLR
pathway, including receptors (TLR4, CD14), signaling molecules
(IRAK1), and inflammatory mediators (TNFα, IL-6, CCL3,
CCL7, CXCL8), and linked to a set of nodes with higher
connectivity as compared to the rest of the network (Figure 6).
Consistent with targeting predictions, over-expression of miR-
125a-5p or let-7e-5p significantly decreased the luciferase activity
of a reporter construct containing the TLR4 3
′
UTR, and a
5-bp deletion in the miR-125a-5p or let-7e-5p MRE fully
restored luciferase levels, indicating the specificity of these
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FIGURE 3 | miR-125a∼99b∼let-7e cluster is induced through an IL-10-mediated autoregulatory loop. (A–C) Monocytes were treated for the indicated time points
with 100 ng/mL LPS (black), 25 ng/mL IL-10 (white), or both stimuli (gray). Results expressed as fold change over unstimulated samples (mean ± SEM; n = 4).
(D–F) Monocytes were cultured with 100 ng/mL LPS, 50 ng/mL IL-10, 50 ng/mL TGFβ and 20 ng/mL Dex for 24 h and cell extracts were subjected to RIP assay using
anti-Ago2 or IgG control Abs. MiR-125a-5p (A,D), let-7e-5p (B,E), and miR-99b-5p (C,F) were measured by Q-PCR in triplicate samples. Results expressed as fold
change over unstimulated samples (mean ± SEM; n = 6). (G–I) Monocytes were stimulated for 12 h with 100 ng/mL LPS after pre-treatment for 30min with the
JAK/STAT inhibitor AG-490 (5µM) or its vehicle (black and white columns, respectively) or in the presence of anti-IL-10R (10µg/mL) or isotype control MoAb (black
and white columns, respectively). MiR-125a-5p (G), let-7e-5p (H), and miR-99b-5p (I) were measured by Q-PCR in triplicate samples. Results expressed as fold
change over control (mean ± SEM; n = 6). (*<0.05; **<0.01; ***<0.001).
miRs for their predicted target sites in the TLR4 transcript
(Figure 7A). When the human monocytic cell line THP-1, a
well-established model for in vitro studies of the TLR signaling
pathway (29), was transduced with lentiviral vectors over-
expressing miR-125a or let-7e (miR-125a OE and let-7e OE,
respectively), a significant enrichment of the TRL4 transcript
in the RISC was observed, as compared to cells transduced
with the control vector (CT) (Figure 7B). In a complementary
approach, cells transduced with lentiviral vectors expressing
artificial mRNA targets to inhibit miR-125a-5p or let-7e-5p
(miR-125a-5p sponge and let7e-5p sponge, respectively) showed
a significant decrease in the TLR4 transcript enrichment
in the RISC after LPS stimulation as compared to cells
transduced with the control vector (CT) (Figure 7C). Finally,
when compared to control vector-transduced cells, TLR4
protein levels were significantly decreased in cells transduced
with miR-125a OE and let7e OE and significantly increased
in cells transduced with miR-125a-5p sponge and let7e-5p
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FIGURE 4 | Interferon antagonizes the induction of miR-125a∼99b∼let-7e cluster. (A–C) Expression of miR-125a-5p, let-7e-5p and miR-99b-5p in monocytes
cultured for 24 h with 100 ng/mL LPS (black), 20 ng/mL IFNγ (white) or both stimuli (gray) for the indicated times. MiR-125a-5p (A), let-7e-5p (B), and miR-99b-5p
(C) were measured by Q-PCR in triplicate samples. Results expressed as fold change over control (mean ± SEM; n = 4). (D) ChIP assays were carried out on
monocytes stimulated or not for 24 h with 25 ng/ml IL-10, 100 ng/ml LPS, or 10 ng/ml IFNγ using a monoclonal antibody recognizing SP1. Q-PCR was carried out
using primers specific for the predicted SP1 binding sites in the miR-125a∼99b∼let-7e promoter, located at the distances from the TSS indicated in Figure 2A.
Results are expressed as fold change over control (mean ± SEM; n = 4). (*<0.05; **<0.01; ***<0.001).
sponge (Figures 7D,E). Taken together, these data validated the
predicted direct targeting of TLR4 by both miR-125a-5p and
let7e-5p. Using a similar approach, the direct targeting of the
second LPS receptor CD14 and the TLR signaling molecule
IRAK1 were also demonstrated for miR-125a-5p but not let7e-
5p, consistent with targeting predictions (Figures 8A–D, 9A–D,
respectively).
Bioinformatics predictions of miR-125a-5p and let-7e-5p
targets also included a relevant number of LPS-dependent
pro-inflammatory cytokines (Figure 6; green and red indicate
miR-125a-5p and let-7e-5p target genes, respectively, targets of
both miRs are in yellow). Luciferase assays validated the TNFα
transcript as a direct target of miR-125a-5p, and mutations
at the corresponding MRE abolished miR125a-5p-mediated
suppression, demonstrating sequence specificity of the targeting
(Figure 10A). Consistent with this, RIP analysis revealed a
significant enrichment of the TNFα transcript in miR-125a OE
transduced THP-1 cells (Figure 10B) and a parallel decrease
of the TNFα transcript in the RISC when miR-125a-5p was
inhibited (Figure 10C). Similar approaches confirmed IL-6 and
CCL7 targeting by let-7e-5p (Figures 10D–I, respectively), while
CCL3 and CXCL8 were validated as targets of both miR-125a-5p
and let-7e-5p (Figures 10J–O, respectively). Expression of miR-
125a-5p and let-7e-5p caused a significant reduction of most but
not all their direct targetmRNA, indicating that depending on the
specific transcript either mRNA destabilization or transduction
inhibition could be involved in their inhibitory effect
(Figure S1).
Frontiers in Immunology | www.frontiersin.org 7 September 2018 | Volume 9 | Article 2037
Curtale et al. miR-125a∼let-7e∼miR-99b Controls TLR Signaling Pathway
FIGURE 5 | Inflammatory genes are enriched in miR-125a∼99b∼let-7e cluster predicted target genes. (A) Absolute number and percentage of miR-125a-5p,
let-7e-5p, and miR-99b-5p predicted target genes included in the Immune system process genonthology category (GO term 0002376) and in the relative
subcategories Immune response (dark gray), Antigen processing and presentation (light gray), and Macrophage activation (blue). (B) Molecular and cellular functions
significantly enriched in predicted target genes of miR-125a-5p (green), let-7e-5p (red), and miR-99b-5p (brown) as identified by the IPA analysis. The number of
molecules involved and the p value calculated with the right-tailed Fisher’s exact test are reported in the color code corresponding to each miR.
The miR-125a∼99b∼let-7e Cluster Inhibits
LPS-Dependent Production of
Inflammatory Cytokines
As we demonstrated the direct targeting of multiple components
of the TLR4 signaling pathway by miR-125a-5p and let-7e-5p,
their global impact on TLR4 activity was investigated by
evaluating the production of inflammatory cytokines after
LPS exposure. As compared to control cells, miR-125a OE
THP-1 cells showed a significant reduction in LPS-dependent
production of several inflammatory cytokines, including TNFα,
IL-6, IL-12p40, CCL2, CCL3, CCL7, CXCL8, and CXCL10,
while a significant increase of these pro-inflammatory cytokines
was observed when miR-125a-5p was inhibited (miR-125a-
5p sponge THP-1 cells; Figures 11A–H). Similar results were
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FIGURE 6 | Predicted target genes of miR-125a-5p and let-7e-5p in the Inflammatory response molecular network. The Inflammatory response molecular network
was extracted using the IPA analysis knowledge database and used to display functional relationships with predicted target genes of miR-125a-5p (green), let-7e-5p
(red), or both (yellow). Genes not predicted as targets are in black. The Toll-Like receptor pathway (boxed) shows a significant enrichment of genes predicted as direct
targets of the miR-125a∼99b∼let-7e cluster (p = 1.42 × 10−5).
obtained when let-7e-5p was modulated using the same
approaches (Figures 11I–P). Of note, miR-125a-5p and let-
7e-5p showed significant effects on both cytokines identified
as direct targets (TNFα, IL-6, CCL3, CCL7, CXCL8; see
Figure 10) as well as others not predicted as direct targets
(IL-12p40, CCL2, CXCL10; see Figure 6), consistent with a
global effect of these miR on the TLR4 signaling pathway.
After stimulation with LPS, CXCL10 protein levels were also
significantly inhibited in miR-125a OE and let-7e OE THP-
1 cells, and increased in miR-125a-5p sponge and let-7e-5p
sponge THP-1 cells (Figures 11H,P, respectively), while no
effect was observed when this chemokine was induced by IFNγ
(Figures 11Q,R), confirming that the effects of miR-125a-5p
and let-7e-5p were mediated by their specific targeting of the
TLR4 signaling pathway. Taken together, these data indicate
that miR-125a-5p and let-7e-5p operate as anti-inflammatory
miRs dampening down the proinflammatory activity of LPS by
multiple targeting of key components in the TLR4 signaling
pathway.
The miR-125a∼99b∼Let-7e Cluster
Mediates LPS Tolerance
As our results demonstrated that the miR-125a∼99b∼let-7e
cluster was an effective negative regulator of TLR4 signaling, we
investigated its involvement in the induction of LPS tolerance.
As shown in Figures 12A,B, the impaired production of TNFα
observed in LPS tolerant monocytes was paralleled by a
significant increase in their expression of miR-125a-5p, and
the ability of IFNγ to prevent the induction of LPS tolerance,
as shown by IFNγ-dependent rescue of TNFα production,
correlated with its ability to prevent the accumulation of
miR-125a-5p in tolerant monocytes. Consistent with the LPS
tolerant behavior previously described in monocytes (1, 30),
THP-1 cells exposed to TGFβ or IL-10 also significantly
reduced TNFα production after LPS challenge, while IFNγ pre-
treatment strongly enhanced LPS-dependent production and
significantly impaired the tolerization effect of TGFβ and IL-10
(Figure 12C). In this setting, miR-125a-5p inhibition in THP-
1 cells resulted in increased TNFα production as compared to
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FIGURE 7 | MiR-125a-5p and let-7e-5p directly target TLR4. (A) Wild-type or MRE-mutated luciferase constructs based on the 3′UTR of TLR4 were cotransfected in
HEK-293T cells with mimics of miR-125a-5p, let-7e-5p, miR-99b-5p, or a negative control (CT). Results are expressed as mean (% variation ± SEM; n = 6) of the
ratio between renilla luciferase and firefly control luciferase activities. (B,C) Cell extracts from THP-1 cells transduced with miR-125a OE, let-7e OE, or the control
vector CT (B) or with miR-125a-5p sponge, let-7e-5p sponge, or the control vector CT (C) were stimulated for 6 h with LPS and then subjected to RIP assay using
anti-Ago2 or IgG control Abs. TLR4 transcript levels were assayed in triplicate by Q-PCR (mean ± SEM; n = 6) and expressed as normalized fold enrichment in Ago2
IP (black columns) and leftover (white columns). (D–E) Surface molecule protein levels were measured by flow cytometry in THP-1 cells transduced with
over-expressing or sponge vectors (gray bars on the left and right panels, respectively) for miR-125a (D) or let-7e (E) or their corresponding control vectors (black
bars). Isotype control staining are shown in dotted histograms. Results from one representative experiment of 3 performed are shown. (*<0.05; ***<0.001).
CT cells, and blocking TGFβ- or IL-10-induced miR-125a-5p
expression was sufficient to revert their LPS tolerogenic effect
(Figure 12D). Taken together, these results indicate that the
miR-125a∼99b∼let-7e cluster is a molecular effector of IL-10-
and TGFβ-dependent pathways negatively regulating the LPS
inflammatory signal and that miR-125a-5p acts as an intracellular
mediator of LPS tolerance.
DISCUSSION
Excessive inflammation can be detrimental to the host and,
consequently, several regulatory mechanisms have evolved to
control its magnitude and duration (31–33). IL-10 and TGFβ are
key feedback inhibitors of the TLR signaling pathway primarily
acting at both transcriptional (26) and post-transcriptional levels
(27, 34) to inhibit pro-inflammatory cytokines production.
To investigate the potential role of miRs in the post-
transcriptional mechanisms dampening innate immune cell
activation, we extensively characterized the expression of the
evolutionary conserved LPS-responsive miR-125a∼99b∼let-7e
cluster in response to different pro- and anti-inflammatory
signals, including TLR ligands and pro-and anti-inflammatory
cytokines. Our results indicate that the miR-125a∼99b∼let-
7e cluster acts as a gene late-induced by LPS in monocytes
as the effect of an IL-10-dependent regulatory loop and is
counter-regulated by IFNγ, which promotes macrophage classic
pro-inflammatory activation and chronic inflammation (4)
(Figure S2). This expression pattern is consistent with previous
reports showing that expression of both let-7e-5p and miR-
125a-5p is associated with the development of an appropriate
host defense. In particular, let-7e over-expression led to the
rescue of defect in LPS tolerance in AKT-1−−/−− mice (18),
and miR-125a-5p has been proposed to suppress classical
proinflammatory activation and promote the anti-inflammatory
alternative activation of macrophages (35).
The analysis of the core promoter region of miR-
125a∼99b∼let-7e cluster identified different transcriptional
binding sites depending upon pro- or anti-inflammatory
mediators investigated. The three miRs in the cluster were always
coregulated, suggesting they could act coordinately to control
a target biological process. To investigate this hypothesis, we
evaluated their potential involvement in the coregulation of
complex gene regulatory networks adopting a computational
method based on GO term enrichment and IPA analysis,
which revealed that predicted targets of miR-125a-5p and
let-7e-5p were significantly enriched in functional cathegories
associated with the inflammatory response and macrophage
activation in particular, with multiple key genes being predicted
as targets for both miR-125a and let-7e. Computational
methods, complemented by experimental target validation,
made possible the reconstruction of large scale biological gene
networks associated with the list of miR-125a∼99b∼let-7e
cluster predicted targets. Interestingly, the main gene regulatory
network generated by predicted target genes of miR-125a-5p
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FIGURE 8 | MiR-125a-5p directly targets CD14. (A) Wild-type or MRE-mutated luciferase constructs based on the 3’UTR of CD14 were cotransfected in HEK-293T
cells with mimics of miR-125a-5p, let-7e-5p, miR-99b-5p, or a negative control (CT). Results are expressed as mean (% variation ± SEM; n = 6) of the ratio between
renilla luciferase and firefly control luciferase activities. (B,C) Cell extracts from THP-1 cells transduced with miR-125a OE, let-7e OE, or the control vector CT (B) or
with miR-125a-5p sponge, let-7e-5p sponge, or the control vector CT (C) were stimulated for 6 h with LPS and then subjected to RIP assay using anti-Ago2 or IgG
control Abs. CD14 transcript levels were assayed in triplicate by Q-PCR (mean ± SEM; n = 6) and expressed as normalized fold enrichment in Ago2 IP (black
columns) and leftover (white columns). (D) Surface molecule protein levels were measured by flow cytometry in THP-1 cells transduced with over-expressing or
sponge vectors (gray bars on the left and right panels, respectively) for miR-125a or the corresponding control vectors (black bars). Isotype control staining are shown
in dotted histograms. Results from one representative experiment of 3 performed are shown. (*<0.05; ***<0.001).
FIGURE 9 | MiR-125a-5p directly targets IRAK1. (A) Wild-type or MRE-mutated luciferase constructs based on the 3
′
UTR of IRAK1 were cotransfected in HEK-293T
cells with mimics of miR-125a-5p, let-7e-5p, miR-99b-5p, or a negative control (CT). Results are expressed as mean (% variation ± SEM; n = 6) of the ratio between
renilla luciferase and firefly control luciferase activities. (B,C) Cell extracts from THP1 cells transduced with miR-125a OE, let-7e OE, or the control vector CT (B) or
with miR-125a-5p sponge, let-7e-5p sponge, or the control vector CT (C) were stimulated for 6 h with LPS and then subjected to RIP assay using anti-Ago2 or IgG
control Abs. IRAK1 transcript levels were assayed in triplicate by Q-PCR (mean ± SEM; n = 5) and expressed as normalized fold enrichment in Ago2 IP (black
columns) and leftover (white columns). (D) IRAK1 protein levels were evaluated by Western blot in THP-1 cells transduced with over-expressing or sponge vectors (left
and right panels, respectively) for miR-125a. Normalization was performed on β actin levels (lower panels) evaluated on the same blot. Results from one representative
experiment of 3 performed are shown. (*<0.05; ***<0.001).
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FIGURE 10 | Direct targeting of pro-inflammatory cytokines by miR-125a-5p and let-7e-5p. Wild-type of MRE-mutated luciferase constructs based on the 3’UTR of
TNFα (A), IL-6 (D), CCL7 (G), CCL3 (J), and CXCL8 (M) were cotransfected in HEK-293T cells with miR-125a-5p, let-7e-5p, miR-99b-5p mimics or with a negative
control mimic. Results are expressed as mean (% variation ± SEM; n = 5) of the ratio between renilla luciferase and firefly control luciferase activities. Cell extracts
from THP1 cells transduced with miR-125a OE, let-7e OE, and the control vector (CT; panels B,E,H,K,N) or with miR-125a-5p sponge, let-7e-5p sponge, and the
control vector (CT; panels C,F,I,L,O) were stimulated for 6 h with LPS and then subjected to RIP assay using anti-Ago2 or IgG control Abs and levels of TNFα (B,C),
IL-6 (E,F), CCL7 (H,I), CCL3 (K,L), and CXCL8 (N,O). Transcript levels were assayed in triplicate by Q-PCR (mean ± SEM; n = 4) and expressed as normalized fold
enrichment in Ago2 IP (black columns) and leftover (white columns). (*<0.05: **<0.01; ***<0.001).
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FIGURE 11 | MiR-125a-5p and let-7e-5p down-regulate pro-inflammatory cytokines. (A–P) Levels of pro-inflammatory cytokines measured by ELISA in cell-free
supernatants of THP-1 cells transduced with CT, miR-125a OE, and let-7e OE, or with miR-125a-5p sponge, let-7e-5p sponge after stimulation with 1µg/mL LPS for
8 h for TNFα (A,I), CCL3 (E,M), and CXCL8 (G,O), or 24 h for IL-6 (B,J), IL-12p40 (C,K), CCL7 (F,N), CCL2 (D, L), and CXCL10 (H,P). Results of 6 independent
experiments are shown. (Q,R) CXCL10 levels measured by ELISA in cell-free supernatants of THP1 cells transduced with CT, miR-125a OE, and let-7e OE, or with
miR-125a-5p sponge and let-7e-5p sponge, after stimulation with 10 ng/ml IFNγ for 24 h. Results of 5 independent experiments are shown. (*<0.05; **<0.01;
***<0.001).
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FIGURE 12 | MiR-125a-5p is expressed in tolerized monocytes and contributes to IL-10 and TGFβ-dependent tolerance. (A,B) Monocytes were pretreated or not
with 10 ng/ml IFNγ, primed or not with 0.1 ng/ml LPS (1◦LPS) for 18 h, and then challenged with 10 ng/ml LPS (2◦LPS). After 24 h, TNFα levels were measured by
ELISA in cell-free supernatants (A), and expression levels of miR-125a-5p was assayed by Q-PCR in triplicate samples (B). Results are expressed as fold change over
control (mean ± SEM; n = 5). (C) Untransfected THP-1 cells incubated or not ON with 10 ng/ml IFNγ (white and black columns, respectively) were pre-treated or not
with TGFβ or IL-10 for 2 h before stimulation with 100 ng/ml LPS for 48 h. TNFα levels were measured by ELISA in cell free supernatants. Results are shown as mean
± SEM of 3 independent experiments. (D) THP-1 cells transduced with miR-125a-5p sponge or control vectors (white and black columns, respectively) were
pre-treated or not with TGFβ or IL-10 for 2 h before stimulation with 100 ng/ml LPS for 48 h. TNFα levels were measured by ELISA in cell free supernatants. Results
are shown as mean ± SEM of 5 independent experiments. (*<0.05; **<0.01; ***<0.001).
and let-7e-5p was an “inflammatory network” significantly
enriched of nodes and edges centered on the TLR pathway.
Notably, miR-99b-5p, which has an overall significantly lower
number of predicted targets when compared to miR-125a-5p
and let-7e-5p (1171 vs. 6148 and 4891 target genes, respectively),
was not predicted to be actively involved in the modulation
of the TLR pathway. The observation that also miR-99b-5p
target genes are enriched in the genonthology category Immune
system (Figure 5A) but in different functional subcategories as
compared to the target genes of the other two miR (Figure 5B)
suggests the association of this miR with different aspects of
the immune response. In particular, miR-99b-5p not only is not
involved in the regulation of the TLR pathway, but target gene
enrichment analysis also does not support evidence for its role in
macrophage activation (Figure 5B). On the contrary, this miR,
and not miR-125a-5p and let-7e-5p, is significantly enriched
for genes associated with the subcategory Cellular growth and
profileration part of the Immune system genonthology category
GO term 0002376 (Figure 5B), and it is tempting to speculate
it might be involved in controlling the emeriging potential
of macrophage to profilerate (36). Collectively, these results
indicated that miR-125a-5p and let-7e-5p cooperatively regulate
key genes of the TLR4 signaling pathway, possibly acting in
concert through the subtle individual regulation of multiple
genes rather than operating a strong repression of isolated
targets, a multistep approach previously described in other
biological settings (18, 37). This pervasive regulation involved
targeting of common components at multiple levels of the TLR
signaling pathway, including receptors (e.g., TLR4 and CD14)
and signal transducers (e.g., IRAK1), with the resulting effect
of a global suppression of downstream inflammatory cytokine
levels. This biological function is consistent with the induction
of miR-125a∼99b∼let-7e cluster by agonists activating different
TLR/IL-1R pathways and highlights the importance of multiple
checkpoints in the signaling cascade to allow the controlled
development of an appropriate inflammatory response. We
also demonstrated the induction of miR-125a∼99b∼let-7e
cluster expression by IL-10 and TGFβ and showed evidence
that this induction is biologically relevant, as miR-125a-5p
mediated IL-10- and TGFβ-dependent tolerance to LPS. In this
setting, our evidence showing the negative regulation of this
miR cluster by IFNγ and the ability of miR-125a-5p inhibition
to reverse the tolerance state point to the down-regulation
of this miR cluster as one of the mechanisms by which IFNγ
induce a state of refractoriness to the suppressive effects of
TGFβ and IL-10 (Figure S2). Consistent with this, we showed
that manipulation of this miR cluster significantly shapes the
profile of inflammatory cytokines induced downstream by TLR
agonists.
In conclusion, our findings identified the miR-125a∼99b∼let-
7e cluster as a new key intracellular mediator used by the
master anti-inflammatory cytokine IL-10 to dampen down
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the pro-inflammatory TLR pathway and provides a new
perspective in the understanding of mechanisms by which
the inflammatory response is regulated in phagocytes. Further
studies are required to fully disclose the role of miR-125a-5p
and let-7e-5p in the resolution of inflammation and in endotoxin
tolerance and to evaluate the potential of their exploitation
to develop novel therapeutic approaches for inflammatory
diseases.
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